Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy

zu Verbundenen Objekten

Standort
Deutsche Nationalbibliothek Frankfurt am Main
ISSN
2629-3277
Umfang
Online-Ressource
Sprache
Englisch
Anmerkungen
online resource.

Erschienen in
Cardiac Protection after Systemic Transplant of Dystrophin Expressing Chimeric (DEC) Cells to the mdx Mouse Model of Duchenne Muscular Dystrophy ; volume:15 ; number:6 ; day:15 ; month:10 ; year:2019 ; pages:827-841 ; date:12.2019
Stem cell reviews and reports ; 15, Heft 6 (15.10.2019), 827-841, 12.2019

Urheber
Siemionow, Maria
Malik, M.
Langa, P.
Cwykiel, J.
Brodowska, S.
Heydemann, A.
Beteiligte Personen und Organisationen
SpringerLink (Online service)

DOI
10.1007/s12015-019-09916-0
URN
urn:nbn:de:101:1-2020040902575165557702
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
14.08.2025, 10:51 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Original beim Datenpartner anzeigen

Beteiligte

  • Siemionow, Maria
  • Malik, M.
  • Langa, P.
  • Cwykiel, J.
  • Brodowska, S.
  • Heydemann, A.
  • SpringerLink (Online service)

Ähnliche Objekte (12)

Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy

Dystrophin Expressing Chimeric (DEC) Human Cells Provide a Potential Therapy for Duchenne Muscular Dystrophy

Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy

Altered social behavior and ultrasonic communication in the dystrophin-deficient mdx mouse model of Duchenne muscular dystrophy

Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy

Dystrophin Dp71 and the Neuropathophysiology of Duchenne Muscular Dystrophy

Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy

Dual exon skipping in myostatin and dystrophin for Duchenne muscular dystrophy

Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice

Systemic delivery of full-length dystrophin in Duchenne muscular dystrophy mice

Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy

Creation of Dystrophin Expressing Chimeric Cells of Myoblast Origin as a Novel Stem Cell Based Therapy for Duchenne Muscular Dystrophy

Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up

Dystrophin Expressing Chimeric (DEC) Cell Therapy for Duchenne Muscular Dystrophy: A First-in-Human Study with Minimum 6 Months Follow-up

Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model

Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model

Kraniofaziale Morphologie bei mdx-Mäusen mit Dystrophin-Mangel

Hochschulschrift

Kraniofaziale Morphologie bei mdx-Mäusen mit Dystrophin-Mangel

Chimeric Cell Therapy Transfers Healthy Donor Mitochondria in Duchenne Muscular Dystrophy

Chimeric Cell Therapy Transfers Healthy Donor Mitochondria in Duchenne Muscular Dystrophy

Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy

Dystrophin and mini-dystrophin quantification by mass spectrometry in skeletal muscle for gene therapy development in Duchenne muscular dystrophy

Deletion pattern in the dystrophin gene in Duchenne muscular dystrophy patients in northeast India

Deletion pattern in the dystrophin gene in Duchenne muscular dystrophy patients in northeast India

Verbundene Objekte